title: Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelination attacks.
abstract: In order to examine the endogenous antioxidants values in the earliest phase of demyelination, we have determined bilirubin and uric acid (UA) serum values in the patients with clinically isolated syndrome (CIS) and relapsing remitting multiple sclerosis (RRMS), regarding their clinical disability, measured by Extended Disability Status Scale (EDSS), Magnetic Resonance Imaging (MRI), disease duration, gender and other parameters. The bilirubin and UA levels were lower in CIS and RRMS patients than in control group, whether male or female (p < 0.05). The bilirubin and UA levels were decreased in RRMS compared to CIS patients (p < 0.05). Regarding EDSS, MRI and disease duration, obtained values of bilirubin and UA were higher in both study groups in patients with lower EDSS, lower MRI lesion number and shorter disease duration (p < 0.05). The greatest significance in decreased bilirubin and UA levels was observed in female compared to male patients, in both study groups (p < 0.05). The results suggest negative linear correlation between bilirubin and UA levels and disease duration, EDSS and MRI in CIS (p < 0.01), with the same correlation between bilirubin and UA levels and disease duration in RRMS patients (p < 0.01). There was also significant correlation between bilirubin level and MRI findings and UA levels and EDSS in RRMS patients (p < 0.01). The obtained results point to the importance of endogenous antioxidants in the outbreak and course of neuroinflammation. This could be favorable for the new pathogenetically conditioned neuroinflammatory therapy concepts which do not initially rely only on immunomodulatory, but also on the antioxidative effects.
authors.affiliation: Clinic of Neurology, Clinical Centre Nis, Bul. Dr Zorana Djindjica 48, 18000, Nis, Serbia, srljub@gmail.com.
authors.forename: Srdjan
authors.initials: S
authors.lastname: Ljubisavljevic
authors.forename: Ivana
authors.initials: I
authors.lastname: Stojanovic
authors.forename: Slobodan
authors.initials: S
authors.lastname: Vojinovic
authors.forename: Maja
authors.initials: M
authors.lastname: Milojkovic
authors.forename: Olivera
authors.initials: O
authors.lastname: Dunjic
authors.forename: Dragan
authors.initials: D
authors.lastname: Stojanov
authors.forename: Dusica
authors.initials: D
authors.lastname: Pavlovic
mesh_terms: D000293:Adolescent; D000328:Adult; D001663:Bilirubin / Q000097:blood*; D001921:Brain / Q000473:pathology*; D003711:Demyelinating Diseases / Q000097:blood* / Q000473:pathology; D004185:Disability Evaluation; D018450:Disease Progression; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000097:blood* / Q000473:pathology; D014527:Uric Acid / Q000097:blood*
chemical_list: D014527:Uric Acid; D001663:Bilirubin